Anticancer therapy using glucuronate modified long-circulating liposomes
- 10 November 1999
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 40 (1-2) , 63-73
- https://doi.org/10.1016/s0169-409x(99)00040-x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Effect of serum protein binding on real-time trafficking of liposomes with different charges analyzed by positron emission tomographyBiochimica et Biophysica Acta (BBA) - Biomembranes, 1996
- Delivery of Molecular Medicine to Solid TumorsScience, 1996
- Antitumor activity of vincristine encapsulated in glucuronide-modified long-circulating liposomes in mice bearing Meth A sarcomaBiochimica et Biophysica Acta (BBA) - Biomembranes, 1996
- Tumor imaging with technetium-99m-DTPA encapsulated in RES-avoiding liposomesNuclear Medicine and Biology, 1993
- Liposomal modification with uronate, which endows liposomes with long circulation in vivo, reduces the uptake of liposomes by J774 cells in vitroLife Sciences, 1992
- Tumor accumulation of novel RES-avoiding liposomesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomesFEBS Letters, 1990
- Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing miceJournal of Photochemistry and Photobiology B: Biology, 1990
- Glucuronate-modified liposomes with prolonged circulation time.CHEMICAL & PHARMACEUTICAL BULLETIN, 1989
- Large unilamellar liposomes with low uptake into the reticuloendothelial systemFEBS Letters, 1987